(HealthDay)—Possible reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been observed at a skilled nursing facility (SNF) in Kentucky, according to research published
Read more
Home » SARS-CoV-2 »
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), are being administered worldwide. A successful, safe and
Read more
Researchers in the UK have shown that the increased transmissibility of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage B.1.1.7 that emerged in the
Read more
Researchers in Italy have conducted a study showing that patients who had tested positive for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) still
Read more
Caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, coronavirus disease 2019 (COVID-19) is speculated to be involved in various pulmonary and cardiometabolic conditions.
Read more
A SARS-CoV-2 tracker uses publicly available sequencing data to show how the virus is changing and spreading over time. The tracker, called CovMT, was developed
Read more
(HealthDay)—Substantial reductions in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and symptomatic COVID-19 have been reported following administration of one dose of the BNT162b2 COVID-19
Read more
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), resides in mucous membranes, making it easy to detect viral
Read more
The coronavirus disease 2019 (COVID-19) pandemic – caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – is still causing hundreds of thousands of
Read more
(HealthDay)—CRISPR-based assays appear to be reliable for surveillance testing and detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreaks in higher education settings, according
Read more